摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-2-Benzoyl-1-<(3,4-dimethoxyphenyl)methylene>-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | 104621-37-6

中文名称
——
中文别名
——
英文名称
(Z)-2-Benzoyl-1-<(3,4-dimethoxyphenyl)methylene>-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
英文别名
1-(3,4-dimethoxybenzylidene)-2-benzoyl-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline;2-Benzoyl-1-(3,4-dimethoxybenzylidene)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline;[(1Z)-1-[(3,4-dimethoxyphenyl)methylidene]-6,7-dimethoxy-3,4-dihydroisoquinolin-2-yl]-phenylmethanone
(Z)-2-Benzoyl-1-<(3,4-dimethoxyphenyl)methylene>-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline化学式
CAS
104621-37-6
化学式
C27H27NO5
mdl
——
分子量
445.515
InChiKey
GMKYVBRSWLJBBE-HMAPJEAMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    33
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    57.2
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (Z)-2-Benzoyl-1-<(3,4-dimethoxyphenyl)methylene>-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolinelead(IV) acetate 作用下, 以 为溶剂, 反应 20.5h, 生成 [2-Benzoyl-6,7-dimethoxy-3,4-dihydro-2H-isoquinolin-(1Z)-ylidene]-(3,4-dimethoxy-phenyl)-acetic acid methyl ester
    参考文献:
    名称:
    Lead tetraacetate mediated oxidation of the enamides derived from 1-benzyl-3,4-dihydroisoquinolines
    摘要:
    DOI:
    10.1021/jo00241a011
  • 作为产物:
    描述:
    3,4-二氢罂粟碱氯化苄吡啶 作用下, 以74%的产率得到(Z)-2-Benzoyl-1-<(3,4-dimethoxyphenyl)methylene>-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
    参考文献:
    名称:
    Lead tetraacetate mediated oxidation of the enamides derived from 1-benzyl-3,4-dihydroisoquinolines
    摘要:
    DOI:
    10.1021/jo00241a011
点击查看最新优质反应信息

文献信息

  • Process for preparing N-acyltetrahydroisoquinoline
    申请人:Takasago Perfumery Co., Ltd.
    公开号:EP0245960A2
    公开(公告)日:1987-11-19
    A process for preparing an N-acyltetrahydro­isoquinoline represented by formula (II) wherein A repesents a phenylene ring substituted with a hydroxyl group, a Cl-4 alkoxy, acetoxy, or benzyloxy group; R represents a hydrogen atom, a Cl-1 alkyl, or phenyl group; and X represents a hydrogen atom, a phenyl group, or a phenyl group substituted with a hydroxyl group, a lower alkoxy group or an acetoxy group, which comprises asymmetrically hydrogenating a solution of an N-acyl-1-­methylenetetrahydroisoquinoline or N-acyl-1-benzylidene­tetrahydroisoquinoline represented by formula (I) wherein A, R, and X are as defined above, in solution at a H₂ pressure of 1 to 10 kg/cm² at 10 to 40°C for 10 to 160 hours, in the presence as catalyst of an optically active ruthenium-phosphine complex, of which several examples are given. The process exclusively and efficiently provides a useful isomer of the N-actyltetrahydroisoquinoline of high purity which is useful as an intermediate for synthesizing isoquinoline type alkaloids as pharmaceuticals without involving optical resolution of a racemate.
    一种制备由式(II)代表的N-酰基四氢异喹啉的工艺 其中 A 代表被羟基、Cl-4 烷氧基、乙酰氧基或苄氧基取代的苯基环;R 代表氢原子、Cl-1 烷基或苯基;X 代表氢原子、苯基或被羟基、低级烷氧基或乙酰氧基取代的苯基、 其中包括不对称地氢化由式(I)代表的 N-酰基-1-亚甲基四氢异喹啉或 N-酰基-1-亚苄基四氢异喹啉的溶液 其中 A、R 和 X 如上定义,在光学活性膦络合物作为催化剂存在下,于 10 至 40°C 下,在 1 至 10 kg/cm² 的 H₂ 压力下,在溶液中进行 10 至 160 小时。 该工艺独家有效地提供了一种有用的高纯度 N-内酰四氢异喹啉异构体,该异构体可用作合成异喹啉生物碱的中间体,而不涉及外消旋体的光学解析。
  • Asymmetric synthesis of isoquinoline alkaloids by homogeneous catalysis
    作者:Ryoji. Noyori、Masako. Ohta、Yi. Hsiao、Masato. Kitamura、Tetsuo. Ohta、Hidemasa. Takaya
    DOI:10.1021/ja00282a054
    日期:1986.10
  • General asymmetric synthesis of isoquinoline alkaloids. Enantioselective hydrogenation of enamides catalyzed by BINAP-ruthenium(II) complexes
    作者:Masato Kitamura、Yi Hsiao、Masako Ohta、Masaki Tsukamoto、Tetsuo Ohta、Hidemasa Takaya、Ryoji Noyori
    DOI:10.1021/jo00081a007
    日期:1994.1
    In the presence of a small amount of RuX(2)[(R)- or (S)-BINAP] (X = anionic ligand) a wide range of (Z)-2-acyl-1-benzylidene-1,2,3,4-tetrahydroisoquinolines are hydrogenated to give the saturated products in nearly quantitative yields and in high (up to 100 %) optical yields. The enamide substrates are selectively prepared by N-acylation of the corresponding 1-benzylated 3,4-dihydroisoquinolines under suitable acylation conditions; some crystalline materials having low solubility are obtained by a second-order Z/E stereomutation technique utilizing the double-bond photolability and lattice energy effects. This asymmetric hydrogenation sets the key stereogenic center in a predictable manner, either R or S flexibly, at the C(1) position of the benzylated tetrahydroisoquinolines. The chiral products are converted by standard functional group modification to tetrahydropapaverine, laudanosine, tretoquinol, norreticuline, etc. Hydrogenation of the simple 1-methylene substrate is used fbr synthesis of salsolidine. This enantioselective hydrogenation is applied to the synthesis of morphine and its artificial analogues such as morphinans and benzomorphans of either chirality. A mnemonic device is presented for predicting the reactivity and enantiofacial selection of the BINAP-Ru catalyzed hydrogenation. Reaction with BINAP-Rh catalyst proceeds with a lower enantioselectivity and an opposite sense of asymmetric induction.
  • NOYORI, RYOJI;KITAMURA, MASATO;TAKAYA, HIDEMASA;KUMOBAYASHI, HIDENORI;AKU+
    作者:NOYORI, RYOJI、KITAMURA, MASATO、TAKAYA, HIDEMASA、KUMOBAYASHI, HIDENORI、AKU+
    DOI:——
    日期:——
  • US4851537A
    申请人:——
    公开号:US4851537A
    公开(公告)日:1989-07-25
查看更多